According to Allogene Therapeutics 's latest financial reports the company's current earnings (TTM) are -โน22.73 B. In 2023 the company made an earning of -โน26.39 B an increase over its 2022 earnings that were of -โน28.15 B.The earnings displayed on this page is the company's Pretax Income.